Company profile
Blue Ash Therapeutics company profile
Blue Ash Therapeutics, LLC (BAT) is a privately funded company, formed in December 2008 in Cincinnati to bring a promising cardiovascular drug – azimilide - to market. BAT acquired the license for global development of azimilide dihydrochloride from Warner Chilcott in January 2010. After reactivating the azimilide IND, BAT formed a Cincinnati-based clinical and regulatory development team that met with the FDA and gained agreement, via the Special Protocol Assessment (SPA) process, for the design and sizing of a single Phase III trial as the final efficacy study needed for marketing approval. In April 2011 the azimilide license and global..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Contact email
- [email protected]
- Phone number
- (513) 554-0696
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Revenue range
- $1K+
- Founded
- 2008-01-01
Headquarters
- Headquarters
- Cincinnati, Ohio, United States
- Postal code
- 45246
- Country code
- US
- Continent
- North America